or Try an Advanced Search...

    Technical Analysis for TYRA - Tyra Biosciences, Inc.

    Grade Last Price % Change Price Change
    C 18.98 2.93% 0.54
    TYRA closed down 0.75 percent on Wednesday, May 15, 2024, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical TYRA trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Overbought Strength 2.93%
    Inside Day Range Contraction 2.93%
    Wide Bands Range Expansion 2.93%
    Overbought Stochastic Strength 2.93%
    50 DMA Support Bullish 2.15%
    Wide Range Bar Range Expansion 2.15%
    Doji - Bearish? Reversal 2.15%
    Doji - Bullish? Reversal 2.15%
    Outside Day Range Expansion 2.15%
    Wide Bands Range Expansion 2.15%
    Older End-of-Day Signals for TYRA ...

       Recent Intraday Alerts

    Alert Time
    Up 5% about 4 hours ago
    Up 3% about 5 hours ago
    Rose Above Previous Day's High about 6 hours ago
    Up 2% about 6 hours ago
    60 Minute Opening Range Breakout about 6 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TYRA Chart by TradingView
    Basic chart:

    Profile

    Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2-related cancers, FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Tumor Cell Biology Tyrosine Kinase Receptors Bladder Cancer Fibroblast Growth Factor Fibroblast Growth Factor Receptor Preclinical Stage Biopharmaceutical Clusters Of Differentiation

    Is TYRA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans
    May 10 Tyra Biosciences GAAP EPS of -$0.35 beats by $0.11
    May 9 Tyra Biosciences Reports First Quarter 2024 Financial Results and Highlights
    May 7 Tyra Biosciences Announces Appointments of Susan Moran, M.D., M.S.C.E. and S. Michael Rothenberg, M.D., Ph.D. to its Board of Directors
    Mar 20 Tyra Biosciences Inc (TYRA) Reports Increased R&D Investments Amid Pipeline Progress
    Mar 19 Tyra Biosciences GAAP EPS of -$0.53 misses by $0.05
    Mar 19 Tyra Biosciences files to sell 15.37M shares of common stock for holders
    Mar 19 Tyra Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights
    Mar 6 Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 9,152 Shares
    Mar 1 Insider Sell: Tyra Biosciences Inc (TYRA) COO Daniel Bensen Sells 8,644 Shares
    See more TYRA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.67
    52 Week Low 10.47
    Average Volume 143,887
    200-Day Moving Average 15.00
    50-Day Moving Average 17.04
    20-Day Moving Average 17.07
    10-Day Moving Average 18.13
    Average True Range 1.17
    RSI (14) 59.68
    ADX 26.47
    +DI 22.89
    -DI 12.90
    Chandelier Exit (Long, 3 ATRs) 15.88
    Chandelier Exit (Short, 3 ATRs) 17.63
    Upper Bollinger Bands 19.71
    Lower Bollinger Band 14.44
    Percent B (%b) 0.76
    BandWidth 30.88
    MACD Line 0.52
    MACD Signal Line 0.35
    MACD Histogram 0.1703
    Fundamentals Value
    Market Cap 965.24 Million
    Num Shares 52.3 Million
    EPS -1.39
    Price-to-Earnings (P/E) Ratio -13.27
    Price-to-Sales 0.00
    Price-to-Book 4.30
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 20.48
    Resistance 3 (R3) 20.37 19.59 20.14
    Resistance 2 (R2) 19.59 19.07 19.64 20.03
    Resistance 1 (R1) 19.01 18.75 18.62 19.12 19.91
    Pivot Point 18.23 18.23 18.03 18.28 18.23
    Support 1 (S1) 17.65 17.71 17.26 17.76 16.97
    Support 2 (S2) 16.87 17.39 16.92 16.85
    Support 3 (S3) 16.29 16.87 16.74
    Support 4 (S4) 16.40